Get started
Author

Patrik Kehler

Observed names: Kehler, Patrik, Kehler, Patrik 1986-
ORCID: 0009-0004-4557-059X
Observed ORCID: 0009-0004-4557-059X
OpenAlex ID: A5083308293
GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies
2024 · Johanna Gellert, Anika Jäkel, et al. · International Journal of Molecular Sciences · 9
PDF
CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
2023 · Anna Christina Dragon, Luca Marie Beermann, et al. · Frontiers in Immunology · 7
PDF
Targeting a cancer-specific LYPD3 glycoform for tumor therapy
2023 · Theresa Neumann, Evelyn Hartung, et al. · Frontiers in Drug Discovery · 3
1347 Targeting of a cancer-associated LYPD3 glycoform for tumor therapy
2022 · Patrik Kehler, Theresa Neumann, et al. · Regular and Young Investigator Award Abstracts · 3
PDF
Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas
2025 · Melina Umland, Anna Christina Dragon, et al. · Transfusion Medicine and Hemotherapy · 2
PDF
781 GT-001 - anti-Lewis Y antibody with superior fine-specificity and reduced off-target binding
2021 · Anika Jaekel, Patrik Kehler, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
1346 Antibodies against GlycoTargets as novel platform approach to address unmet needs in cancer therapy
2022 · Patrik Kehler, Theresa Neumann, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Abstract 316: Carbohydrate-dependent protein binding antibodies with superior tumor-specificity
2022 · Patrik Kehler, Anika Jaekel, et al. · Cancer Research · 1
712 Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties
2021 · Anika Jaekel, Patrik Kehler, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Abstract 7184: GT-008: A monoclonal antibody enabling selective radionuclide delivery to a tumor-associated glycosylation form of CD24 - Preclinical proof-of-concept study
2026 · Johanna Gellert, Andreas Franz, et al. · Cancer Research
Abstract 3429: Improving druggability of a promising tumor target by the novel glycosylation-dependent mAb GT-008 for treatment of solid tumors
2025 · Johanna Gellert, Andreas Franz, et al. · Cancer Research
Abstract 5896: Platform approach to develop antibodies specifically recognizing cancer-associated glycoforms
2024 · Patrik Kehler, Johanna Gellert, et al. · Cancer Research
1462 Antibodies specifically recognizing cancer-associated glycoforms of mucin-like proteins
2023 · Theresa Neumann, Evelyn Hartung, et al. · Regular and Young Investigator Award Abstracts
PDF
Abstract 1588: Using glyco-engineered cells with flexible expression of tumor-associated carbohydrates for the generation of highly tumor-specific antibodies
2023 · Patrik Kehler, Naomi Kast, et al. · Cancer Research
Abstract 2879: Preclinical characterization of GT-00A x IL15: A novel IL-15-based immunocytokine with unique tumor targeting properties
2022 · Patrik Kehler, Anika Jaekel, et al. · Cancer Research
Abstract 3231: The chimeric co-stimulatory receptor PD1-41BB enhances the function of T cell receptor (TCR)-modified T cells targeting solid tumors
2020 · Nadja Sailer, Melanie Salvermoser, et al. · Cancer Research
Entwicklung und Charakterisierung verschiedener neuartiger bispezifischer Antikörper basierend auf PankoMab-GEX™ zur Verbesserung der Tumortherapie
2018 · Kehler, Patrik · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
Works count: 18
Citation count: 29
H-index: 3
I10-index:
Year
Topic
Type